These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8868456)

  • 1. [Interferon-alpha-induced psoriasis vulgaris].
    Wölfer LU; Goerdt S; Schröder K; Zouboulis CC; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):124-8. PubMed ID: 8868456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exacerbation of psoriasis by treatment with alpha interferon].
    Revenga Arranz F; Castaño Suárez E; Vanaclocha Sebastián F
    Med Clin (Barc); 1994 Dec; 103(20):800. PubMed ID: 7861842
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon alfa-2a.
    Williams CD; Linch DC
    Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection.
    Seçkin D; Durusoy C; Sahin S
    Pediatr Dermatol; 2004; 21(5):577-9. PubMed ID: 15461767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exacerbation of psoriasis during alpha-interferon therapy].
    Hartmann F; von Wussow P; Deicher H
    Dtsch Med Wochenschr; 1989 Jan; 114(3):96-8. PubMed ID: 2912680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
    Stuart-Harris RC; Lauchlan R; Day R
    Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
    Gori A; Caredda F; Franzetti F; Ridolfo A; Rusconi S; Moroni M
    Lancet; 1995 Jun; 345(8962):1438-9. PubMed ID: 7760627
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
    de Wit R; Schattenkerk JK; Boucher CA; Bakker PJ; Veenhof KH; Danner SA
    Lancet; 1988 Nov; 2(8622):1214-7. PubMed ID: 2903953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon.
    Halmos O; Inturri P; Galligioni A; Di Landro D; Rigotti P; Tedeschi U; Graziotto A; Burra P; Poletti A; Rossaro L
    Clin Transplant; 1996 Aug; 10(4):374-8. PubMed ID: 8884111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.
    Sulis E; Floris C; Sulis ML; Zurrida S; Piro S; Pintus A; Contu L
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):759-61. PubMed ID: 2714351
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.
    Afshar M; Martinez AD; Gallo RL; Hata TR
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):771-8. PubMed ID: 22671985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C.
    Wu MC; Lee JY
    Australas J Dermatol; 2012 Nov; 53(4):e69-72. PubMed ID: 23157789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of cytokine treatment in malignant skin tumors.
    Garbe C
    Recent Results Cancer Res; 1995; 139():349-69. PubMed ID: 7597303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
    Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
    J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
    Ladoyanni E; Nambi R
    J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
    Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
    Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.